• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Outbreak of mumps in a student population with high vaccination coverage in China: time for two-dose vaccination.中国高疫苗接种率人群中发生流行性腮腺炎暴发:需要进行两剂疫苗接种。
Hum Vaccin Immunother. 2019;15(9):2106-2111. doi: 10.1080/21645515.2019.1581526. Epub 2019 Mar 15.
2
Assessment of mumps-containing vaccine effectiveness during an outbreak: Importance to introduce the 2-dose schedule for China.评估腮腺炎疫苗在暴发期间的有效性:对中国引入 2 剂次程序的重要性。
Hum Vaccin Immunother. 2018 Jun 3;14(6):1392-1397. doi: 10.1080/21645515.2018.1428508. Epub 2018 Feb 15.
3
Mumps disease in Beijing in the era of two-dose vaccination policy, 2005-2016.2005-2016 年北京市两剂次免疫政策后流行性腮腺炎发病特征分析
Vaccine. 2018 May 3;36(19):2589-2595. doi: 10.1016/j.vaccine.2018.03.074. Epub 2018 Apr 10.
4
Assessing the Changes of Mumps Characteristics with Different Vaccination Strategies Using Surveillance Data: Importance to Introduce the 2-Dose Schedule in Quzhou of China.利用监测数据评估不同疫苗接种策略下腮腺炎特征的变化:在中国衢州引入 2 剂程序的重要性。
J Immunol Res. 2020 Mar 27;2020:8130760. doi: 10.1155/2020/8130760. eCollection 2020.
5
Loss of protective immunity of two-dose mumps-containing vaccine over time: concerns with the new strategy of the mumps immunization program in China.随着时间的推移,两剂含腮腺炎疫苗的保护免疫力丧失:对中国腮腺炎免疫计划新策略的关注。
Hum Vaccin Immunother. 2021 Jul 3;17(7):2072-2077. doi: 10.1080/21645515.2020.1861877. Epub 2021 Feb 5.
6
[Evaluation on the short term effectiveness of two doses mumps-containing vaccine policy in Shandong, China].[中国山东两剂含腮腺炎疫苗政策的短期效果评估]
Zhonghua Yu Fang Yi Xue Za Zhi. 2018 Mar 6;52(3):265-270. doi: 10.3760/cma.j.issn.0253-9624.2018.03.009.
7
Effectiveness of Rubella vaccine in a rubella outbreak in Guangzhou city, China, 2014.2014年中国广州市风疹疫情中风疹疫苗的有效性
Vaccine. 2015 Jun 22;33(28):3223-7. doi: 10.1016/j.vaccine.2015.04.083. Epub 2015 May 16.
8
Assessment of mumps-containing vaccine effectiveness by dose during 2006 to 2020 in Quzhou, China.2006 年至 2020 年期间中国衢州含腮腺炎成分疫苗剂量的效力评估。
Hum Vaccin Immunother. 2022 Nov 30;18(5):2086774. doi: 10.1080/21645515.2022.2086774. Epub 2022 Jun 8.
9
Mumps vaccination coverage and vaccine effectiveness in a large outbreak among college students--Iowa, 2006.2006年爱荷华州大学生群体中大规模腮腺炎疫情的疫苗接种覆盖率及疫苗效力
Vaccine. 2008 Jul 4;26(29-30):3601-7. doi: 10.1016/j.vaccine.2008.04.075. Epub 2008 May 19.
10
Outbreak-related mumps vaccine effectiveness among a cohort of children and of young adults in Germany 2011.2011年德国一组儿童和年轻人中与疫情相关的腮腺炎疫苗有效性
Hum Vaccin Immunother. 2014;10(1):140-5. doi: 10.4161/hv.26642. Epub 2013 Oct 7.

引用本文的文献

1
Development and characterization of the genotype F attenuated mumps candidate strains.基因型F减毒腮腺炎候选菌株的开发与特性研究
Front Immunol. 2025 Jul 22;16:1629585. doi: 10.3389/fimmu.2025.1629585. eCollection 2025.
2
Risk factors for mumps in children under 15 years of age during the transition from single-dose to two-dose MMR vaccination strategy: a matched case-control study.在从单剂量麻疹-腮腺炎-风疹(MMR)疫苗接种策略过渡到双剂量接种策略期间15岁以下儿童患腮腺炎的危险因素:一项配对病例对照研究
Front Public Health. 2025 Jul 7;13:1592602. doi: 10.3389/fpubh.2025.1592602. eCollection 2025.
3
Epidemiological characteristics and interrupted time series analysis of mumps in Quzhou City, 2005-2023.2005-2023 年衢州市流行性腮腺炎的流行病学特征及中断时间序列分析。
Hum Vaccin Immunother. 2024 Dec 31;20(1):2411828. doi: 10.1080/21645515.2024.2411828. Epub 2024 Oct 17.
4
A Multi-Age-Group Interrupted Time-Series Study for Evaluating the Effectiveness of National Expanded Program on Immunization on Mumps.一项用于评估国家扩大免疫规划对腮腺炎效果的多年龄组中断时间序列研究。
Vaccines (Basel). 2022 Sep 21;10(10):1587. doi: 10.3390/vaccines10101587.
5
Preponderance of vaccine-preventable diseases hotspots in northern Ghana: a spatial and space-time clustering analysis from 2010 to 2014.加纳北部疫苗可预防疾病热点居多:2010 年至 2014 年的空间和时空聚类分析。
BMC Public Health. 2022 Oct 12;22(1):1899. doi: 10.1186/s12889-022-14307-1.
6
Assessment of mumps-containing vaccine effectiveness by dose during 2006 to 2020 in Quzhou, China.2006 年至 2020 年期间中国衢州含腮腺炎成分疫苗剂量的效力评估。
Hum Vaccin Immunother. 2022 Nov 30;18(5):2086774. doi: 10.1080/21645515.2022.2086774. Epub 2022 Jun 8.
7
Introduction of Two-Dose Mumps-Containing Vaccine into Routine Immunization Schedule in Quzhou, China, Using Cox-Proportional Hazard Model.中国衢州采用 Cox 比例风险模型将含腮腺炎两剂疫苗纳入常规免疫接种计划。
J Immunol Res. 2021 Nov 5;2021:5990417. doi: 10.1155/2021/5990417. eCollection 2021.
8
Mumps Orchitis: Clinical Aspects and Mechanisms.流行性腮腺炎睾丸炎:临床方面和发病机制。
Front Immunol. 2021 Mar 18;12:582946. doi: 10.3389/fimmu.2021.582946. eCollection 2021.
9
Loss of protective immunity of two-dose mumps-containing vaccine over time: concerns with the new strategy of the mumps immunization program in China.随着时间的推移,两剂含腮腺炎疫苗的保护免疫力丧失:对中国腮腺炎免疫计划新策略的关注。
Hum Vaccin Immunother. 2021 Jul 3;17(7):2072-2077. doi: 10.1080/21645515.2020.1861877. Epub 2021 Feb 5.
10
Effects of extreme meteorological factors on daily mumps cases in Hefei, China, during 2011-2016.极端气象因素对 2011-2016 年中国合肥地区每日流行性腮腺炎发病的影响。
Environ Sci Pollut Res Int. 2020 Feb;27(4):4489-4501. doi: 10.1007/s11356-019-07073-y. Epub 2019 Dec 12.

本文引用的文献

1
Seroprevalence and Determinants Associated with Mumps Antibodies after 20 Years of MMR Vaccination in Urban Area of Shanghai, China.中国上海城区 20 年麻腮风疫苗接种后腮腺炎抗体的血清阳性率及相关决定因素。
Int J Environ Res Public Health. 2018 Sep 23;15(10):2089. doi: 10.3390/ijerph15102089.
2
Characteristics of Large Mumps Outbreaks in the United States, July 2010-December 2015.美国 2010 年 7 月至 2015 年 12 月大规模流行性腮腺炎爆发的特征。
Clin Infect Dis. 2019 May 2;68(10):1684-1690. doi: 10.1093/cid/ciy779.
3
Assessment of one-dose mumps-containing vaccine effectiveness on wild-type genotype F mumps viruses circulating in mainland China.评估含腮腺炎成分疫苗一剂接种对在中国流行的野生型基因型 F 腮腺炎病毒的效果。
Vaccine. 2018 Sep 11;36(38):5725-5731. doi: 10.1016/j.vaccine.2018.08.028. Epub 2018 Aug 16.
4
Mumps in the Vaccination Age: Global Epidemiology and the Situation in Germany.接种疫苗时代的腮腺炎:全球流行病学和德国的情况。
Int J Environ Res Public Health. 2018 Jul 31;15(8):1618. doi: 10.3390/ijerph15081618.
5
Mumps disease in Beijing in the era of two-dose vaccination policy, 2005-2016.2005-2016 年北京市两剂次免疫政策后流行性腮腺炎发病特征分析
Vaccine. 2018 May 3;36(19):2589-2595. doi: 10.1016/j.vaccine.2018.03.074. Epub 2018 Apr 10.
6
Vaccine waning and mumps re-emergence in the United States.疫苗效力减弱与美国流行性腮腺炎再现
Sci Transl Med. 2018 Mar 21;10(433). doi: 10.1126/scitranslmed.aao5945.
7
Assessment of mumps-containing vaccine effectiveness during an outbreak: Importance to introduce the 2-dose schedule for China.评估腮腺炎疫苗在暴发期间的有效性:对中国引入 2 剂次程序的重要性。
Hum Vaccin Immunother. 2018 Jun 3;14(6):1392-1397. doi: 10.1080/21645515.2018.1428508. Epub 2018 Feb 15.
8
Effectiveness of a Third Dose of MMR Vaccine for Mumps Outbreak Control.第三剂麻腮风疫苗在控制腮腺炎疫情中的有效性。
N Engl J Med. 2017 Sep 7;377(10):947-956. doi: 10.1056/NEJMoa1703309.
9
Mumps Epidemiology and Mumps Virus Genotypes Circulating in Mainland China during 2013-2015.2013 - 2015年中国大陆流行性腮腺炎流行病学及流行的腮腺炎病毒基因型
PLoS One. 2017 Jan 13;12(1):e0169561. doi: 10.1371/journal.pone.0169561. eCollection 2017.
10
[Epidemic profile of mumps in China during 2004-2013].2004 - 2013年中国腮腺炎流行概况
Zhonghua Yu Fang Yi Xue Za Zhi. 2016 Jul 6;50(7):611-4. doi: 10.3760/cma.j.issn.0253-9624.2016.07.009.

中国高疫苗接种率人群中发生流行性腮腺炎暴发:需要进行两剂疫苗接种。

Outbreak of mumps in a student population with high vaccination coverage in China: time for two-dose vaccination.

机构信息

Department of Expanded Program on Immunization, Lu'an Municipal Center for Disease Control and Prevention , Lu'an , Anhui , China.

Chinese Field Epidemiology Training Program (CFETP), Chinese Center for Disease Control and Prevention , Beijing , China.

出版信息

Hum Vaccin Immunother. 2019;15(9):2106-2111. doi: 10.1080/21645515.2019.1581526. Epub 2019 Mar 15.

DOI:10.1080/21645515.2019.1581526
PMID:30779678
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6773387/
Abstract

In 2016, an outbreak of mumps occurred in a primary school in China with a student population having high vaccination coverage. An unmatched case-control study was performed to identify risk factors contributing to this outbreak, and a retrospective cohort study was conducted to evaluate the effectiveness of mumps-containing vaccine (MuCV). A total of 97 cases were identified during the outbreak, and the overall attack rate was 8.2%. Among students with confirmed vaccination status, 90% had received at least one dose of MuCV. Cases were more likely than non-cases to report taking the school bus during the epidemic period (adjusted OR = 2.3, 95% CI: 1.4-3.7). Vaccine effectiveness (VE) was higher for two-dose MuCV (76%, 95% CI:49â€"89%) than for one-dose MuCV (59%, 95% CI: 36â€"74%. The protection afforded by both one-dose and two-dose MuCV waned over time, from 82% among students vaccinated within 5 years to 41% among those vaccinated more than 10 years previously for one-dose VE, and from 90% to 25% over the same time period for two-dose VE. We found that outbreaks of mumps can occur in schools despite high coverage of one-dose MuCV vaccination. Although the VE of both two-dose and one-dose MuCV wanes over time, the overall VE for two-dose MuCV was superior than that of one-dose MuCV. Therefore, a two-dose MuCV schedule through routine services is likely needed in order to control mumps epidemics in China.

摘要

2016 年,中国一所小学发生了腮腺炎暴发疫情,学生人群的疫苗接种率很高。为了确定导致此次暴发的危险因素,我们开展了一项病例对照研究,并进行了一项回顾性队列研究来评估含腮腺炎成分疫苗(MuCV)的效果。暴发期间共发现 97 例病例,总发病率为 8.2%。在有明确接种状态的学生中,90%至少接种过一剂 MuCV。病例较对照更有可能在流行期间乘坐校车(校正 OR=2.3,95%CI:1.4-3.7)。两剂 MuCV 的疫苗效果(VE)高于一剂 MuCV(76%,95%CI:49%-89%)和 59%(95%CI:36%-74%)。一剂和两剂 MuCV 的保护作用随着时间的推移而减弱,一剂 VE 从接种后 5 年内的 82%降至 10 年以上的 41%,两剂 VE 从接种后 90%降至 5 年内的 25%。我们发现,尽管一剂 MuCV 的接种率很高,但腮腺炎仍可在学校暴发。虽然两剂和一剂 MuCV 的 VE 随时间推移而减弱,但两剂 MuCV 的总体 VE 优于一剂 MuCV。因此,为了控制中国的腮腺炎流行,可能需要通过常规服务接种两剂 MuCV。